Apollon Secures 2.3 Billion KRW in Funding for Innovative Needle-Free CGM Technology
Apollon, a South Korean biotech startup that is developing a needle-free continuous glucose monitoring system (CGM), has successfully raised 2.3 billion...
Apollon, a South Korean biotech startup that is developing a needle-free continuous glucose monitoring system (CGM), has successfully raised 2.3 billion...